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ABSTRACT
Collagen XVIII can generate two fragments, NC11-728 containing a frizzled motif which possibly acts in Wnt sig-
naling and Endostatin, which is cleaved from the NC1 and is a potent inhibitor of angiogenesis. Collagen XVIII and
Wnt signaling have recently been associated with adipogenic differentiation and obesity in some animal models, but
not in humans. In the present report, we have shown that COL18A1 expression increases during human adipogenic dif-
ferentiation. We also tested if polymorphisms in the Frizzled (c.1136C>T; Thr379Met) and Endostatin (c.4349G>A;
Asp1437Asn) regions contribute towards susceptibility to obesity in patients with type 2 diabetes (113 obese, BMI
≥30; 232 non-obese, BMI < 30) of European ancestry. No evidence of association was observed between the allele
c.4349G>A and obesity, but we observed a significantly higher frequency of homozygotes c.1136TT in obese (19.5%)
than in non-obese individuals (10.9%) [P = 0.02; OR = 2.0 (95%CI: 1.07-3.73)], suggesting that the allele c.1136T
is associated to obesity in a recessive model. This genotype, after controlling for cholesterol, LDL cholesterol, and
triglycerides, was independently associated with obesity (P = 0.048), and increases the chance of obesity in 2.8 times.
Therefore, our data suggest the involvement of collagen XVIII in human adipogenesis and susceptibility to obesity.
Key words: COL18A1, obesity, adipogenesis, endostatin, frizzled.
INTRODUCTION
COL18A1, located at chromosome 21q22.3, was first
shown to have an important role in humans when we
demonstrated that homozygous null mutations in this
gene causeKnobloch syndrome (KS) (Sertié et al. 2000).
Correspondence to: Maria Rita Passos Bueno
E-mail: passos@ib.usp.br
KS is an autosomal recessive condition characterized
by vitreo and retinal degeneration, macular abnormal-
ities and occipital encephalocele (KS; OMIM 267750).
The importance of collagen XVIII in retinal angiogen-
esis was further confirmed through the observation of
ocular delayed hyaloid vessel regression in knockout
col18a-/- mice (Fukai et al. 2002).
Collagen XVIII is an important proteoglycan of
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most basement membranes of the body which belongs
to a distinct class of nonfibrillar collagens, called mul-
tiplexins. This protein forms homotrimers and contains
a N-terminal non-collagenous domain (NC-11), 10 col-
lagenous repeats alternated with 9 non-collagenous re-
peats and a C-terminal non-collagenous region, NC-1
(Oh et al. 1994, Saarela et al. 1998). COL18A1 can be
transcribed as 3 distinct isoforms by use of two promoters
and an alternative splicing of the third exon. The three
encoded collagen XVIII proteins differ only by their sig-
nal peptides and by part of the N-terminal region of the
NC11 domain, which contain respectively 303 (NC11-
303), 493 (NC11-493) and 728 (NC11-728) amino acid
residues (Saarela et al. 1998, Elamaa et al. 2003). Colla-
genXVIII presents high expression levels in liver, kidney,
retina and adipose tissue and the predominant isoform
varies according to the tissue type (Saarela et al. 1998,
Suzuki et al. 2002, Elamaa et al. 2003, NCBI UniGene
Hs.517356).
At least two functional fragments can be released
from collagen XVIII: Endostatin, a 20 kDa fragment
cleaved from the NC1 region- common to the three col-
lagen XVIII isoforms (ES-C18) (O’Reilly et al. 1997,
John et al. 2005) and the N-terminal Frizzled cysteine-
rich domain cleaved from the NC11-728 variant (Friz-
zled-C18) (Elamaa et al. 2003). ES-C18 is a potent in-
hibitor of endothelial cell proliferation and migration
with the ability to reduce tumor growth (O’Reilly et
al. 1997, Sasaki et al. 1998). Collagen XVIII and ES-
C18 play several other functions, including apoptosis
induction (Dhanabal et al. 1999, Schmidt et al. 2004)
and maintenance of vascular permeability (Moulton et
al. 2004). The Frizzled-C18 motif shows homology to
secreted frizzled related proteins (sFRP). These proteins
can block Wnt signaling either by interacting with Wnts
to prevent them from binding to frizzled receptors or
forming nonfunctional complexes with them (Wodarz
and Nusse 1998). The function of the soluble Frizzled-
C18 motif is still unknown, but it is possibly involved
in Wnt signaling as sFRPs does (Elaama et al. 2003,
Quelard et al. 2006).
Although the molecular mechanisms regulated by
collagen XVIII and its NC11 and NC1 functional frag-
ments are still being investigated, it is unquestionable the
functional role of collagenXVIII in angiogenesis. There-
fore, variability in quantity or quality of collagen XVIII
and its related fragments could be associated with the
predisposition of human disorders dependent on angio-
genesis (Passos-Bueno et al. 2006). Substantial evidence
has established that growth of solid tumors is angiogen-
esis dependent whereas angiogenesis inhibition prevents
it and can lead to regression of the lesions (Udagawa
et al. 2002, Folkman 2002). Although we and others
were not able to confirm the association between the
SNPAsp 1437Asn (D104N) at the endostatin region and
prostate cancer (Iughetti et al. 2001, Macpherson et al.
2004, Passos-Bueno et al. 2006), several reports have
shown that lower ES-C18 levels have been correlated
with a worse tumor prognosis (Musso et al. 2001) and
that the SNP D104N might be associated with breast
cancer (Lourenço et al. 2006, Balasubramanian et al.
2007). Therefore, analysis of COL18A1 gene SNPs in
diseases in which angiogenesis plays a role can pro-
vide further insights in the functional importance of this
molecule in humans.
Adipose tissue is very unique as it can grow and
regress throughout adulthood. Its growth, which can
arise through increases in cell size (due to accumula-
tion of triglycerides) and/or cell number (due to prolif-
eration of preadipocytes and their subsequent differen-
tiation into mature adipocytes), is largely angiogenesis
dependent (Rupnick et al. 2002, Cao 2007, Nishimura
et al. 2007). Collagen XVIII, which is abundant in adi-
pose tissue (NCBI UniGene Hs.517356), is involved in
angiogenesis control and it has been shown that its tran-
scription levels increase during bovine adipocyte differ-
entiation (Inoue-Murayama et al. 2000). However, the
function of collagen XVIII in the molecular control of
adipogenesis and obesity is very poorly characterized
and it has not yet been investigated in humans. There-
fore, in this study we have first evaluated if COL18A1
mRNA levels vary during in vitro adipogenesis of hu-
man adipose tissue-derived stem cells. In addition, we
also aimed to verify if collagen XVIII would have any
effect on the predisposition of obesity, as this is known
to be a major risk factor for several diseases such as
type 2 diabetes mellitus (DM2) and cardiovascular disor-
ders. To achieve this goal, we tested if SNP c.1136C>T
(Thr379Met), which is being here described for the first
time, andSNPc.4349G>A(Asp1437Asn) are associated
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with obesity in a cohort of Brazilian patients with DM2.
These SNPs are missense mutations in the coding region
of the human COL181A and are located respectively in
the NC11-728 (Frizzled-C18) and Endostatin (ES-C18)
domains of the protein.
MATERIALS AND METHODS
In vitro ADIPOGENIC DIFFERENTIATION
Adipose tissue-derived mesenchymal stem cells were
obtained from lipoaspirates of abdominal subcutaneous
fat. The cells were isolated and cultured as described
previously (Zuk et al. 2002, Costa et al. 2008, Bueno
2007). Their differentiation into adipocytes was induced
by treatment of semi-confluent cells for 14 days with
DMEM-HG supplemented with 10% FBS (Hyclone),
1µM dexamethasone, 100µM indomethacin, 500µM 3-
isobutyl-1-methylxanthine (IBMX), and 10µg/ml in-
sulin as standard protocol (Zuk et al. 2002). To assess
neutral lipid content at day 14 after exposure to inducers
of differentiation, mature adipocytes were washed with
PBS, fixed with 4% paraformaldehyde and stained with
Oil Red O. A successful differentiation process was con-
sidered when it was observed that the majority of cells
accumulated lipid vesicles in the cytoplasm. The use of
human lipoaspirates to establish stem cell populations
was accordingly to the guidelines of our local Ethical
Committee.
QUANTITATIVE REAL-TIME PCR (QRT-PCR)
RNA extraction was conducted with trizol (Gibco) re-
agent at days 0 (no adipogenic induction medium), 3, 7
and 14 of the differentiation process. 5µg of total RNA
was treated with 5 units of RQ1 RNase- Free DNAse
(Promega). cDNAs were synthesized from 1µg of total
RNA using SuperScript II (Invitrogen). Quantitative real
time PCRwas performed with SYBRGreen PCRmaster
mix in an ABI Prism 7100 system (Applied Biosystems)
and approximately 50 ng of cDNA was used to final re-
action volume of 25µL. The primers used in this study
are listed in Table I; the COL18A1 primers amplify all
isoforms. The PCR conditions were: 94◦C for 15 sec-
onds, 60◦C for 30 seconds, and 72◦C for 30 seconds for
45 cycles. The four samples acquired from adipogenic
differentiation (time points 0, 3, 7 and 14 days) were
submitted to qRT-PCR and the threshold cycle (ct) for
each individual PCR product was calculated by the in-
strument software. Ct was calculated with the differ-
ence between sample Cts of each time point of differ-
entiation and reference sample, which was the time 0 of
differentiation. And Cts was calculated based on the
efficiency of each primer. GeNorm (Vandesompele et
al. 2002) was used to obtain the normalization factor for
each sample based on the 2 best endogenous controls that
the program selects. Among the 4 internal control genes
analyzed (GAPDH, SDHA,HMBS andHPRT1) GeNorm
program selectedGAPDH and SDHA to generate the nor-
malization factor used to normalize the samples Cts.
DM2 PATIENTS
We have conducted a case-control study with a total of
345 unrelated patients with DM2. One hundred thirty
five patients were ascertained at the Endocrinology De-
partment, Hospital das Clínicas – USP, while the re-
maining 210 patients are enrolled in a large collabora-
tive study of Diabetes at the University of Rio Grande do
Sul, and detailed clinical description can be found else-
where (Canani et al. 2005, Errera et al. 2007). Briefly,
patients with DM2 were identified from a multicentric
study that started recruiting patients in southern Brazil
in 2002. That project originally aimed to study risk fac-
tors for chronic complications of diabetes. It included
four centers located at general hospitals in the state of
Rio Grande do Sul, namely Grupo Hospitalar Nossa Se-
nhora daConceição, Hospital SãoVicente de Paula, Hos-
pital Universitário de Rio Grande, and Hospital de Clíni-
cas de Porto Alegre. In this study, the ethnical groups
were defined based on self-classification and subjective
classification (color skin, nose and lip shapes, hair tex-
ture and information about family ancestry). All patients
are of European ancestry (mainly from Portugal, Spain,
Italy andGermany). Patients ofAfrican ancestry or those
who defined themselves as having mixed or other ances-
try were not included. The ethical committees of the
participant Institutions approved this study and blood
samples were drawn only after signature of the informed
consent. Patients underwent a standardized evaluation
consisting of a questionnaire, physical examination and
laboratory tests. Diagnosis of DM2 was based on the
guidelines of the Expert Committee report of the Amer-
ican Diabetes Association (American Diabetes Associa-
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TABLE I
Sequence of the primers used in the Quantitative Real-Time PCR experiment.
Gene Sense Primer (5′ → 3′) Antisense Primer (5′ → 3′)
SDHA TGGGAACAAGAGGGCATCTG CCACCACTGCATCAAATTCATG
HPRT1 TGACACTGGCAAAACAATGCA GGTCCTTTTCACCAGCAAGCT
HMBS GGCAATGCGGCTGCAA GGGTACCCACGCGAATCAC
GAPDH CCATCTTCCAGGAGCGAGAT TTCTCCATGGTGGTGAAGAC
LPL CTGGCATTGCAGGAAGTCTG GCATCATCAGGAGAAAGACGA
COL18A1 AAGGACGAGCTGCTGTTTCC TTGCCGTCAAAGGAGAAGATG
tion, 2005). Hypertension was defined as blood pressure
≥ 140/90 mmHg, or use of antihypertensive medica-
tion. Weight without shoes and in light outdoor clothes
and height were measured, and body mass index (BMI)
was calculated as weight/height2 (kg/m2). Obesity was
classified according Word Health Organization (WHO)
criteria (World Health Organization 2000). Patients with
BMI ≥ 30 kg/m2 were considered cases and patients
with BMI < 30 kg/m2 as controls.
PERIPHERAL BLOOD COLLECTION, DNA EXTRACTION
AND BIOCHEMICAL DOSAGES
Genomic DNA was extracted from peripheral blood
leucocytes with salting-out procedure as previously de-
scribed (Miller et al. 1988). In diabetic patients, glucose
was determined by a glucose oxidase method; creatinine
by the Jaffé reaction; A1c test by an ion-exchange HPLC
procedure (Merck-Hitachi L-9100 Glycated hemoglobin
analyzer; reference range: 2.7-4.3%; Merck, Darmas-
tadt, Germany), and triglyceride and cholesterol levels
by enzymatic methods. Albuminuria was measured by
immunoturbidimetry (SERA-PAK immuno Microal-
buminuria; Bayer, Tarrytown, NY, mean intra- and in-
terassay CV: 4.5% and 7.6%, respectively). Total choles-
terol, HDL cholesterol and triglycerides were measured
by standard enzymatic methods.
ANALYSIS OF SNPS IN THE COL18A1 GENE CODING
REGIONS OF FRIZZLED AND ENDOSTATIN
SNPs c.1136C>T (Thr379Met) and c.4349G>A
(Asp1437Asn) were analyzed by SNuPE (Single Nu-
cleotide Primer extension – Amersham Pharmacia)
method. Exons 3 (coding region of frizzled domain) and
42 (coding region of endostatin domain) of COL18A1
gene were amplified using PCR buffer, 0.2 mM dNTPs,
0.6µM of each primer; 0.2 U Taq polymerase, in 35 cy-
cles with 100 ng of DNA, according to the following
steps: 5 minutes denaturation at 95◦C, 10 minutes ex-
tention at 72◦C, and using the following primers and
respective annealing temperature: exon 3F : cccaacca-
cctccaccacgaga and exon 3R: ctggatgaaccgcagccgatgt
(66◦C); 42F : acaaacacccacacccatc and 42R: gaaactgca-
gataggaggccc (59◦C). PCR products were submitted to
SNuPE reaction and then analyzed in automatic se-
quencer (MegaBACETM 1000 DNA Analysis Systems),
using the correspondent software and following the
User’s guide instructions (General Electrics Health Sci-
ence) and 2 pmols of oligonucleotide [c.1136C>T: CG-
AGGAAGGGGTGGCAGTGC, and c.4349G>A: GG-
GCACGCATCTTCTCCTTT (5’-3’)].
STATISTICAL ANALYSIS
Statistical analysis was performed using the SPSS pack-
age (SPSS forWindows, version 10.0). Continuous vari-
ableswere expressed bymean and standard deviation and
the groups were compared by unpaired Student t test.
Allele frequencies were determined by gene counting,
and departures from the Hardy–Weinberg equilibrium
(HWE) were verified using the χ2 test. Genotype and
allele frequency were compared among different groups
by χ2 Test or Fisher’s exact test. A P value < 0.05 was
considered statistically significant. Logistic regression
analysis was performed to assess the independent role of
the COL18A1 genotypes in obesity. Sample size power
was calculated with PS Power and Sample Size Calcula-
tions (Version 2.1.30) (Dupont and Plummer 1998).
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RESULTS
COL18A1 GENE EXPRESSION DURING HUMAN
ADIPOGENESIS
On day 14 after inducing adipocyte differentiation of
adipose tissue-derived human mesenchymal stem cells
(hMSCs), we observed that the majority of cells accu-
mulated lipid droplets in the cytoplasm (Fig. 1). In ad-
dition, LPL, an adipogenic marker, was quantified as a
control of the differentiation experiment and it showed
extreme high expression levels after the induction of the
adipogenesis process (Fig. 2). Therefore, we considered
that the stem cell population successfully differentiated
into adipocytes.
COL18A1 expression was analyzed at four time
points (0, 3, 7 and 14 days) during the differentiation
induction and we observed relatively higher expression
of this gene at day 3 of the differentiation processes, when
it increased 2,5 fold in comparison with undifferentiated
cells. At days 7 and 14 the expression was 1.4 and 0.85
fold-higher than that of untreated stem cells (time 0),
respectively (Fig. 2).
ASSOCIATION STUDY BETWEEN COL18A1 AND OBESITY
The main clinical features of the patients are depicted
in Table II. Among the 345 patients analyzed, 113 were
classified as obese (BMI: 34.31 ± 4.64; cases) and 232
as non-obese (BMI: 25.83 ± 2.53; controls). Cases also
had higher waist and hip circumferences as compared
to controls (P< 0.05). They also presented higher tri-
glycerides, total and LDL cholesterol (P<0.05). There
were no differences for other clinical or laboratorial
characteristics. The genotype distribution for SNPs
c.1136C>T and c.4349G>A were in HWE (Table III;
P > 0.05). There was no difference in the genotype
or allelic frequencies of the SNP c.4349G>A between
obese and non-obese patients (P = 0.11). However, a
borderline association between SNP c.1136C>T geno-
types and obesity was found (P = 0.07). Assuming
a recessive model (TT vs. CT+CC), the genotype TT
was significantly more frequent in obese diabetic pa-
tients (22/113, 19.5%) than in non-obese diabetic pa-
tients (25/232, 10.5%; χ2 = 4.73 and P = 0.02). In
this model, patients with TT genotype had an odds ra-
tio (OR) of 2.57 (95% CI: 1.21-5.47) for obesity. This
effect was more pronounced if we exclude individuals
with overweight, that is those with BMI between 28
and 30 kg/m2 [TT genotype frequency in controls (BMI
< 27 kg/m2, 12/140) was 8.5% (χ2 = 6.38 and P =
0.01)]. In a logistical model, after controlling for choles-
terol, triglycerides, LDL cholesterol levels, the TT geno-
type still held associated with the presence of obesity
(P = 0.048; OR 2,8 CI 95% 1.01-7.74).
DISCUSSION
In the present work, we have shown for the first time that
human collagen XVIII mRNA levels increase during dif-
ferentiation of human mesenchymal stem cells (hMSCs)
into adipocytes. Its transcription profile observed dur-
ing the differentiation process suggests that COL18A1
expression increases at an earlier stage of hMSCs adi-
pogenesis, which is comparable to other well known
genes associated with adipocyte differentiation, such as
C/EBPβ and C/EBPδ (Rosen 2005). These results are
in accordance with those observed in the differentiation
of bovine preadipocytes obtained from intramuscular fat
(Inoue-Murayama et al. 2000). Our results thus indicate
that collagen XVIII may play an important role in hu-
man adipogenesis and the higher increase of COL18A1
expression in the early phase of adipogenic differentia-
tion point to the importance of this gene in the adipogenic
commitment of the cells. It was observed that collagen
XVIII expression levels did not vary during adipogene-
sis of the mouse preadipocyte cell line 3T3-L1 (Inoue-
Murayama et al. 2000). It is therefore possible that the
effect of collagen XVIII in adipocyte differentiation de-
pends on the origin of the preadipocyte or it is species
related. It is worth to note that we have used primer
pairs that recognize the three collagen XVIII isoforms
to quantify its expression in human adipocity differenti-
ation, but it would be important to verify if a specific or
all collagen XVIII isoforms are involved in this process.
We have also evaluated whether there was an
association between COL18A1 gene polymorphisms
c.1136C>T and c.4349G>A, located respectively in
theNC11- 728/Frizzled-C18 andNC-1/ES-C18 domains
of collagen XVIII, and obesity in type 2 diabetes pa-
tients. The allele frequency and genotype distribution
for the SNP c.4349G>A in our sample is similar to those
previous reported in the literature (Passos-Bueno et al.
2006) andwe did not observe any evidence of association
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TABLE II
Clinical variables in DM2 patients according to presence of obesity.
Controls (n= 232) Cases (n= 113) P
Gender Female: Male 122:110 77:36
DM duration (years) 12.78 ± 7.7451 12.81 ± 7.17 0.97
Age of DM Diagnosis (years) 48.81 ± 10.33 44.64 ± 9.62 0.07
Current age (years) 60.80 ± 9.60 60.02 ± 8.34 0.47
BMI (kg/m2) 25.83 ± 2.53 34.31 ± 4.64 —
Waist circumference (cm) 92.88 ± 9.29 105.36 ± 12.40 0.00
Hip circumference (cm) 98.48 ± 7.54 114.48 ± 15.33 0.00
Glucose (mg/dl) 172.47 ± 68.43 175.34 ± 66.73 0.78
LDL- cholesterol (mg/dl) 130.27 ± 46.19 147.70 ± 48.05 0.01
HDL-cholesterol (mg/dl) 45.82 ± 12.70 44.06 ± 12.00 0.24
Cholesterol (mg/dl) 202.97 ± 47.14 223.81 ± 53.41 0.02
Creatinine (mg/dl) 1.25 1.29 0.80
Tryglycerides 174.08 (70-238) 216.98 (89-260.8) 0.02
A1c test (%) 7.13 ± 2.36 7.49 ± 2.53 0.31
Systolic Arterial Pressure (mmHg) 142.89 ± 24.02 144.54 ± 20.85 0.62
Diastolic Arterial Pressure (mmHg) 85.35 ± 13.66 87.11 ± 11.93 0.33
TABLE III
Genotypic and allelic distribution for SNP c.1136C>T and
SNP c.4349G>A according to body mass index.
Body Mass Index
> 30 kg/m2 (n = 113) < 30Kg/m2 (n = 232)
SNP c.1136C>T
Genotypes
CC - n (%) 46 (40.7) 111 (47.8)
CT - n (%) 45 (39.8) 96 (41.4)
TT - n (%) 22 (19.5) 25 (10.8)
Alleles
C 60.6% 68.5%
T 39.4% 31.5%
SNP c.4349G>A
Genotypes
GG - n (%) 102 (90.3) 198 (85.4%)
GA - n (%) 11 (9.7) 33 (14.2%)
AA - n (%) 0 (0) 1 (0.4%)
Alleles
G 95.1% 92.5%
A 4.9% 7.5%
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Fig. 1 – Oil red staining of the cells after 14 days of the beginning of adipogenic
differentiation showing accumulated lipid vesicles in the cytoplasm.
Fig. 2 – A) Quantitative real time PCR showing expression of COL18A1 during human adipogenic differentiation in vitro. B) LPL was quantified
as a control of the differentiation experiment and, as expected, it showed high expression levels after the beginning of the adipogenesis process.
between the SNP c.4349G>A and obesity. However,
we observed consistent evidence of association between
SNP c.1136C>T and obesity.
Our results suggest that the allele c.1136T when in
homozygosis increases about two-fold the chance of a
DM2 patient to develop obesity. When overweight DM2
patients were excluded from the control group, we found
a more pronounced difference in c.1136T frequency be-
tween cases and controls, further supporting the asso-
ciation between this SNP and obesity in DM2 patients.
The importance of TT genotype for obesity was still con-
firmed by logistic regression analysis with the following
variables: total cholesterol levels, LDL and triglycerides.
If these variables are taken into account, the chance that
a TT homozygote develops obesity is increased by 2.8
times when compared to CT heterozygotes or CC ho-
mozygotes. Hence, our data suggest that TT genotype
acts as an independent factor for predisposition to obe-
sity in DM2 patients. The observed frequency of TT
genotype in our obese cohort (19.5%) was very close to
the 22% estimate to achieve an acceptable power level
with the sample size available, thus, suggesting that this
association might not represent a false positive result.
However, although both cases and controls are of EA
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and ascertained in a common cohort of patients, we still
cannot exclude the possibility that these results are due
to population stratification.
It is well established that proteins with frizzled mo-
tif act in Wnt signaling through different pathways in
various processes, including adipogenesis, obesity, in-
sulin secretion and DM2 (Ross et al. 2000, Bennett
et al. 2002, Kennel and MacDougald 2005, Guo et
al. 2006). It has been suggested that the N-terminal
portion of collagen XVIII containing the Frizzled-C18
motif could be involved in Wnt signaling (Elaama et al.
2003, Vainio et al. 2003, Marneros and Olsen 2005) and,
more recently, Quelard et al. (2006) showed that the
Frizzled-C18 module acts as an extracellular inhibitor of
Wnt-B-catenin signaling by quenching Wnts in the hep-
atocarcinoma tumor. The SNP c.1136C>T/Thr379Met
is being described in the present work for the first time.
In a comparative genomic analysis we verified that thre-
onine at position 379 is conserved among mammals (hu-
man, rat, mouse, cow, cat) and is substituted for another
polar aminoacid with an uncharged side chain (serine) in
other vertebrates (chicken, xenopus, zebrafish, medaka,
fugu, stickleback), suggesting that this residue might be
important for normal protein function. The frizzled mo-
tif of the NC11-728 has a cysteine-rich domain, that con-
tains 10 cysteine-conserved sites, and threonine 379 is
located very close to the third cysteine residue. There-
fore, it is possible that the presence of a methionine in-
stead of a threonine can partially impair the function
of this domain in preadipocyte proliferation or differ-
entiation through a direct or indirect effect of the Wnt
pathway.
Recently, we verified that allele c.1136T is in link-
age disequilibrium with the G allele of the polymor-
phism –700G>T, which confers higher transcription lev-
els to this collagen in hepatocytes (Armelin-Correa et al.
2005). Therefore, we cannot exclude the possibility that
the mutated allele is in linkage disequilibrium with an-
other one, which would be actually the responsible for
the phenotype.
It has not been reported obesity in patients with
null mutations in the collagen XVIII or in the knockout
col18-/- mice (Suzuki et al. 2002, Fukai et al. 2002).
However, it is possible that the obesity phenotype is in-
duced only in the presence of high food intake or de-
pending on the genetic background of the individual. In
contrast, obesity is very common in Down syndrome pa-
tients, who have three functional copies of COL18A1
gene as the consequence of trissomy of chromosome 21
(Zorick et al. 2001).
COL18A1 and its receptor glypican has been iden-
tified as promising candidate genes to be involved with
body weight and adiposity in DM2 mice (Brown et al.
2005, Gesta et al. 2006), thus supporting our finding
that collagen XVIII is important in adipogenesis and in
obesity of DM2 patients.
In conclusion, the present study shows for the first
time that collagen XVIII mRNA levels increase during
human adipogenesis and that the SNP c.1136C>T in
the frizzled motif of the COL18A1 doubles the chance
of a patient with type 2 diabetes to develop obesity.
Considering the functional role of collagen XVIII in an-
giogenesis and that it may be involved in Wnt signal-
ing, we could speculate that this collagen might act in
the regulation of adipose tissue mass through different
mechanisms: by controlling angiogenesis in fat tissue
and by stimulating the differentiation of mesenchymal
stem cell into mature adipocytes. Therefore, although
preliminary, our present data may be a starting point
towards understanding this novel role of collagen XVIII
in humans.
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RESUMO
Colágeno XVIII pode gerar dois fragmentos, um correspon-
dendo à região NC11-728 contendo o motivo “frizzled”, o
qual possivelmente atua na sinalização Wnt, e outro corres-
pondendo a Endostatina, que é clivada a partir da região NC1
e é uma potente inibidora de angiogênese. Colágeno XVIII
e a via de sinalização Wnt foram recentemente associados
à diferenciação adipogênica e obesidade em alguns modelos
animais, porém ainda não em humanos. No presente trabalho,
mostramos que os níveis de expressão gênica do COL18A1 au-
mentam durante o processo de diferenciação adipogênica em
humanos. Também testamos se polimorfismos localizados no
motivo “Frizzled” (c.1136C>T; Thr379Met) e na região da
Endostatina (c.4349G>A; Asp1437Asn) contribuem na pre-
disposição a obesidade em pacientes com diabetes tipo 2. (113
obesos, BMI ≥ 30; 232 não-obesos, BMI < 30) de ances-
tralidade Européia. Nenhuma evidência de associação entre o
alelo c.4349G>Ae obesidade foi observada, contudo, observa-
mos uma freqüência significativamente maior de homozigotos
c.1136TT em obesos (19.5%) do que em não-obesos (10.9%)
[P = 0.02; OR = 2.0 (95%CI: 1.07-3.73)], sugerindo que
o alelo c.1136T está associado com obesidade conforme um
modelo recessivo. Este genótipo manteve-se associado à obe-
sidade (P= 0.048) mesmo após o controle das variáveis coles-
terol, LDL e triglicérides, e confere um risco 2.8 vezes maior
de obesidade. Portanto, nossos dados sugerem o envolvimento
do colágeno XVIII em adipogênese humana e predisposição
a obesidade.
Palavras-chave: COL18A1, obesidade, adipogênese, endos-
tatina, “frizzled”.
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